VR Logo

Cellectar Biosciences Inc. (CLRB) download report


Healthcare | Biotechnology & Pharma Research

Cellectar Biosciences Inc. (CLRB) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.

IPO Date: 10-Nov-2005

Pres, CEO & Director: Mr. James V. Caruso

Chief Operating Officer: Mr. Jarrod Longcor

Listing: NASDAQ: CLRB

Country: United States

Headquarters: Florham Park, NJ

Website: https://www.cellectar.com

Key Facts

Market cap: $25.15 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-23.90 Mln

Cash: $30.63 Mln

Total Debt: $0.27 Mln

Insider's Holding: 7.35%

Liquidity: Low

52 Week range: $0.34 - 1.32

Shares outstanding: 61,101,300

10 Years Aggregate:

  • CFO: $-111.73 Mln
  • EBITDA: $-122.53 Mln
  • Net Profit: $-119.47 Mln

Stock Performance

Time Period Cellectar Biosciences (CLRB) S&P BSE Sensex S&P Small-Cap 600
YTD-37.88-8.71-17.92
1 month-6.82-3.11-7.88
3 months-38.81-7.30-13.56
1 Year-67.720.48-17.16
3 Years-41.9910.346.95
5 Years-51.5811.436.30
10 Years-57.8612.1010.29
As on 28-Jun-2022
Year Cellectar Biosciences (CLRB) S&P Small-Cap 600 S&P BSE Sensex
2021-68.2725.2721.99
2020-7.569.5715.75
201945.1620.8614.38
2018-88.55-9.705.87
201712.3011.7327.91
2016-83.4024.741.95
2015-76.21-3.36-5.03